Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine

Breast Cancer Animal Studies Show Unprecedented Anti-Cancer Efficacy of 100% Tumor Growth Inhibition

HONG KONG SAR - Media OutReach Newswire - 11 April 2025 - CK Life Sciences Int'l., (Holdings) Inc.

("CK Life Sciences"), a leader in cancer vaccine development, announces the latest progress in its pharmaceutical R&D, namely the filing of an Original Grant Patent application in Hong Kong and a provisional patent application in the United States for novel cancer vaccines targeting Trophoblast Cell Surface Antigen 2 ("TROP2").

TROP2 is a cell surface glycoprotein that is overexpressed in a wide range of cancers, including breast, lung, pancreatic, and colorectal cancers. This protein plays a critical role in cell proliferation, migration, and invasion, and its overexpression is frequently linked to aggressive tumor behavior and poor clinical outcomes. Given its high expression in cancer cells and minimal presence in normal tissues, TROP2 has emerged as a promising therapeutic target in oncology.

TROP2-positive triple-negative breast cancer animal study demonstrated 100% tumor growth inhibition

TROP2 cancer vaccines covered by the patent application include innovative circular mRNA (circRNA) and fusion protein vaccine constructs that can induce robust T cell immune responses and have demonstrated impressive tumor growth inhibition in preclinical studies of triple-negative breast cancer and colorectal cancer. The results of animal studies involving triple-negative breast cancer ("TNBC") have been encouraging, with mouse models showing 100% tumor growth inhibition after receiving the TROP2 cancer vaccine. Overall, 100% inhibition of tumor growth was achieved in four of the five studies when mice were treated with a TROP2 vaccine candidate, while the remaining study demonstrated approximately 80% tumor growth inhibition.

Triple-negative breast cancer disproportionately prevalent and aggressive among Asian women

The results of animal studies of the TROP2 cancer vaccines are of particular relevance to the Asian region. Breast cancer rates in Asia are rising sharply, with younger women widely affected. In particular, TNBC shows both higher prevalence and more aggressive behavior in Asian populations compared to Western counterparts. Additionally, TNBC has fewer treatment options and demonstrates significantly higher rates of metastasis and recurrence than other breast cancer subtypes.

Unprecedented anti-cancer efficacy

"TROP2 is an exciting therapeutic target and preclinical studies of our cancer vaccine in triple-negative breast cancer exhibited 100% inhibition of tumor growth, demonstrating unprecedented anti-cancer efficacy. We look forward to advancing our TROP2 cancer vaccine expeditiously into clinical trials to benefit patients and believe it holds significant potential in preventing cancer recurrence," said Dr. Melvin Toh, Chief Scientific Officer at CK Life Sciences.

Data on the TROP2 cancer vaccines will be presented at upcoming cancer conferences. In recent years, CK Life Sciences has showcased its growing early-stage cancer vaccine pipeline through preclinical data presentations at leading oncology conferences, alongside the filing of multiple patents. Developed in its Hong Kong-based R&D laboratories, these innovative vaccines target a broad spectrum of tumor antigens, immune checkpoint proteins, and other key components within the tumor-immune microenvironment.




Hashtag: #CKLifeSciences #CancerVaccines #R&D #BreastCancer #PatentApplication #Pharmaceutical

The issuer is solely responsible for the content of this announcement.

About CK Life Sciences

CK Life Sciences Int'l., (Holdings) Inc. (stock code: 0775) is listed on the Stock Exchange of Hong Kong. With a mission of improving the quality of life, CK Life Sciences is engaged in healthcare research and development, with operating businesses that enable its R&D sustainability. Regarding pharmaceutical research and development, CK Life Sciences' operations are focused on conducting research and development into cancer vaccines and pain management solutions. CK Life Sciences is a member of the CK Hutchison Group. For additional information, please visit .

News from Asia

News Lounge Comes to Türkiye, Fostering Dialogue Across Borders

ANTALYA, TURKEY – Media OutReach Newswire – 14 November 2026 – News Lounge, the flagship program of China News Service, welcomed its first group of international guests since its overseas debut in...

TORRAS Launches Two New iPhone Duo Cases from Its Popular Ostand Series, Addressing Foldable Phone Users’ Concerns About Difficult Stand Positioning and Scratches

TOKYO, JAPAN – Media OutReach Newswire – 14 November 2026 – TORRAS (楽創未来株式会社), a mobile accessory brand, has released two stand-equipped iPhone cases compatible with the foldable iPhone Duo...

Sun World Ba Den Mountain marks Vietnam Culture Day, welcoming Cambodian visitors over Bon Om Touk

TAY NINH, VIETNAM – Media OutReach Newswire – 14 November 2026 – Sun World Ba Den Mountain in Tay Ninh province will hold a series of cultural activities marking Vietnam Culture Day on Nov...

Ayam Brand™ Nurtures Healthier Futures with #AyamBersamaMu: Bekal Sihat Masa Depan

The CSR initiative promotes healthier habits among school children through nutrition education, practical food skills, and sustainability, alongside nationwide food donations to orphanages and welf...

Huawei Launches LUTERRA® S2, Redefining the Future of Residential Energy Systems with Three Ultimate Innovations

PALMA, SPAIN – Media OutReach Newswire – 11 November 2026 - Huawei announced the launch of HUAWEI LUTERRA S2, an all-in-one residential energy system that integrates a hybrid inverter, storage, an...

The 27th China International Education Annual Conference held a cloud dialogue, where Yin Yuzhen and Saikaos discussed the exchange of folk ecological education

BEIJING, CHINA – Media OutReach Newswire – 11 November 2026 – The 27th China Annual Conference & Expo for International Education (CACIE) hosted a "CACIE Talk" session in Beijing on October 30...

ATI Secures Manila South Harbour Concession Renewal To 2063

Renewal provides long-term certainty for ATI to advance investment in port modernisation, innovation and sustainable infrastructureMANILA, PHILIPPINES – Media OutReach Newswire – 12 November 2026 ...

Somerset Clarke Quay Singapore To Open On 15 December 2026, As A New Global Flagship For The Somerset Brand

The new flagship property will showcase Somerset's signature approach to harmonious living through active wellness integration, family discovery, and destination-led experiences. SINGAPORE – M...

Ride, eat and save: foodpanda teams up with HelloRide to bring everyday perks to Singaporeans

The partnership connects everyday mobility with food and grocery delivery, giving eligible users more ways to enjoy the convenience of both platformsSINGAPORE – Media OutReach Newswire – 12 Novemb...

SEVENTEEN’s JEONGHAN X JOSHUA Partner With ENYA MUSIC as Global Brand Ambassadors for DREAMSCAPE Collection

The duo JxJ’s co-branded ENYA MUSIC smart instrument series is now available for global pre-order.SHENZHEN, CHINA – Media OutReach Newswire – 12 November 2026 – The core voices behind SEVENTEEN's ...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...